Inventor · disambiguated record
Jörg Holenz
Also filed as: HOLENZ JOERG · HOLENZ JORG · Holenz Jörg
11 granted patents·18 pending applications·47 citations·filing 2004–2024
87Inventor score
Top patents by PatentIndex Score
29 records- 0192US11434236B2Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2020·Granted Sep 6, 2022·2 cites·32 claims
- 0289US7417170B2Process for the preparation of substituted 3-aryl-butylamine compoundsGRUENENTHAL GMBH·Filed 2005·Granted Aug 26, 2008·20 cites·58 claims
- 0385US7629356B2Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical compositionsASTRAZENECA AB·Filed 2008·Granted Dec 8, 2009·9 cites·19 claims
- 0484US10894789B2Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2017·Granted Jan 19, 2021·2 cites·30 claims
- 0582US7855213B2CompoundsASTRAZENECA AB·Filed 2007·Granted Dec 21, 2010·7 cites·16 claims
- 0682US2024400550A1Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0781US8030500B2Substituted isoindoles for the treatment and/or prevention of Aβ- related pathologiesASTRAZENECA AB·Filed 2009·Granted Oct 4, 2011·4 cites·2 claims
- 0880US12084437B2Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2022·Granted Sep 10, 2024·0 cites·4 claims
- 0962US9145380B2Bis-(sulfonylamino) derivatives for use in therapyBYLUND JOHAN·Filed 2008·Granted Sep 29, 2015·1 cites·14 claims
- 1056US2010324072A1Pyrrolopyridine derivatives and their use as bace inhibitorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1156US2011021540A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1256US2009281138A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1354US7504519B2Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agentsESTEVE LABOR DR·Filed 2004·Granted Mar 17, 2009·2 cites·45 claims
- 1453US2009163586A1Bis-(Sulfonylamino) Derivatives in Therapy 205ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1552US2010125081A1New compounds 574ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1650US2010125087A1New compounds 575ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1748US2009131468A1Bis-(Sulfonylamino) Derivatives in Therapy 065ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1847US2008176862A1New Compounds 617ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1945US2011319426A1Substituted IsoindolesHOLENZ JOERG·Filed 2011·Application pending·0 cites
- 2044US2008058349A1New Compounds 318ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2144US2007299087A1New Compounds 319ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2244US2008214577A1New Compounds 320ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2342US2011059992A1New CompoundsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 2439US8048879B2Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicamentsGRUENENTHAL GMBH·Filed 2006·Granted Nov 1, 2011·0 cites·24 claims
- 2539US2008253978A1Derivatives of Pyrrolyltriazine Together with Methods for Obtaining Them and Their Use as Protecting Agents Uv RadiationISDIN SA·Filed 2006·Application pending·0 cites
- 2637US2010105680A1Substituted dimethylcyclobutyl compounds, their preparation and use in medicamentsCUBERES ALTISENT MARIA ROSA·Filed 2007·Application pending·0 cites
- 2736US10053453B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2015·Granted Aug 21, 2018·0 cites·25 claims
- 2836US2008193398A1Derivatives of Heptaazaphenalene, Methods for Obtaining Them, and Their Use as Protecting Agents Against Uv RadiationISDIN SA·Filed 2006·Application pending·0 cites
- 2931US2010292279A1Bis-(Sulfonylamino) Derivatives in TherapyASTRAZENECA AB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jörg Holenz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →